DM
Drugs Made In America Acquisition Corp. Units
DMAAU · NASDAQ
$10.99 +0.00% (+$0.00)
1M +1.56%
Market Cap $257.5M
P/E Ratio 42.25x
Div. Yield -
ROE 3.53%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/E 42.25x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
37 /100
Average ROE 3.53%
ROA 4.15%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.02x
Debt/Equity N/A
Int. coverage N/A
Stability
0 /100
Unstable Beta 0.19x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DMAAU
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Roger Bendelac
Employees
2
Headquarters
New York